Analyzing GLP-1 comparative effectiveness using real-world data

preview_player
Показать описание
Tricia Rodriguez, MPH, PhD, Principal Applied Scientist at Truveta, shares insights from a recent study conducted using Truveta Data around real-world usage patterns among patients taking the ever-popular class of weight loss drugs known as GLP-1s - which includes semaglutide (Ozempic) and tirzepatide (Mounjaro).
  1. Truveta
Рекомендации по теме
Analyzing GLP-1 comparative 0:01:44

Analyzing GLP-1 comparative effectiveness using real-world data

EASD 24: Comparative 0:05:24

EASD 24: Comparative Effectiveness of Empagliflozin and GLP1s in the US

Comparative Effectiveness of 0:06:40

Comparative Effectiveness of a DPP-4 Inhibitor, a Sulfonylurea, a GLP-1 Agonist, and Basal Insulin

Treating Diabetes: Heart 0:52:30

Treating Diabetes: Heart Smart Benefits

Exploring the Science 1:02:44

Exploring the Science and Practice of GLP-1 Receptor Agonists

Darren McGuire | 0:46:40

Darren McGuire | Cardiovascular effects of diabetes medications: Lessons learned from CVOTs

Type 2 Diabetes: 0:02:03

Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality

Scoring Comprehensive T2DM 1:04:19

Scoring Comprehensive T2DM Management Goals: Multifaceted Effects of GLP-1 Receptor Agonists

Exploring Advances in 0:39:11

Exploring Advances in GLP-1 Agonist Therapy

Professor Alice Cheng 0:26:50

Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits

ENDO 2021 Press 0:39:24

ENDO 2021 Press Conference: Obesity

Early GLP-1 RA 0:58:55

Early GLP-1 RA Initiation to Reduce Risks and Improve Long-Term Outcomes in T2DM

Type 2 Diabetes 0:25:23

Type 2 Diabetes - The New Epidemic: How Did We Get Here and What's to Come?

Applying Guidelines and 0:20:47

Applying Guidelines and Evidence to Individualize T2DM Treatment With GLP-1 RAs

New Goals and 0:37:07

New Goals and Therapeutic Options for Type 2 Diabetes Mellitus

Professor Stephen Wiviott 0:34:54

Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'

Doctors explain how 0:03:29

Doctors explain how Wegovy and Ozempic work | 60 Minutes

Reducing Cardiometabolic Risks 0:32:30

Reducing Cardiometabolic Risks and Achieving Glycemic Targets With GLP-1 RAs

ADA 2021 – 0:05:22

ADA 2021 – GRADE: Head-to-head comparison of metformin add-ons for type 2 diabetes | Deborah Wexler...

WARNING Do NOT 0:08:31

WARNING Do NOT take Ozempic or Mounjaro until you watch this

Prevention of Beta-Cells 0:46:48

Prevention of Beta-Cells in Type 2 Diabetes: Is it Possible by Faramarz Ismail-Beigi, MD

Using GLP-1 RAs 1:19:59

Using GLP-1 RAs to Individualize Therapy in T2DM

The Many Lies 0:08:24

The Many Lies About The Ozempic Weight Loss Craze

“Weighing In” on 0:44:36

“Weighing In” on GLP-1 Receptor Agonists for People With HIV

Комментарии
Автор

How are you? Your Content is fantastic, But your video optimization section area is not perfectly up to date. Out of 100, that's a score of only 0.9, that's why your video is not reaching out to the people and you do not have many subscribers, views, likes, watch time, and comments. I think your YouTube channel will make your dream come true. I am waiting for your response.

Abid-np